enGene Therapeutics Inc.
| Security | ENGN / enGene Therapeutics Inc. |
| Institution | Deep Track Capital, LP |
| Latest Disclosed Ownership | 4,317,332 shares |
| Ownership | 6.69% |
Deep Track Capital, LP ownership in ENGN / enGene Therapeutics Inc.
2025-11-18 - Deep Track Capital, LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,317,332 shares of enGene Therapeutics Inc. (US:ENGN). This represents 6.69 percent ownership of the company. In their previous filing dated 2025-11-14 , Deep Track Capital, LP had reported owning 2,239,353 shares, indicating an increase of 92.79 percent.
Institutional Ownership: 13D/G Filings
This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).
| File Date | Effective Date | Form | Prev Shares |
Latest Shares |
ΔShares (Percent) |
Ownership (Percent) |
ΔOwnership (Percent) |
|---|---|---|---|---|---|---|---|
| 2025-11-18 | 2025-11-18 | 2,239,353 | 4,317,332 | 92.79 | 6.69 | 53.09 | |
| 2025-11-14 | 2025-11-14 | 4,557,575 | 2,239,353 | -50.87 | 4.37 | -51.12 | |
| 2025-02-14 | 2025-02-14 | 2,250,000 | 4,557,575 | 102.56 | 8.94 | 71.59 | |
| 2024-02-23 | 2024-02-23 | 2,250,000 | 5.21 |
Legend
- Shares
- The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
- Value
- The total value of the shares as of the effective date. This is provided in the filing.
- Avg. Share Price
- The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
- Class
- This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
- Allocation (%)
- The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
- Change in Allocation
- The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
- Change in Allocation (%)
- The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
- Cost Basis
- The total cost of the shares held. This is calculated as reported shares * avg. share price
- Unrealized Gain/Loss
- This is the market value of the position as of the effective date minus the cost basis.
